摘要：800x600 Normal 0 21 false false false NO-BOK X-NONE X-NONE MicrosoftInternetExplorer4 st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} This article describes unresolved challenges of regulation of nanoparticles, mainly from a European perspective. The authors shall argue that the presently dominant strategy, which in this article will be called “filling in the regulatory gaps”, is unsatisfactory with respect to the management of uncertainty and ignorance associated with development and use of nanoparticles. Its shortcomings resemble those of “the modern model” and “the precautionary model” described by Funtowicz ( 2006) and Funtowicz and Strand (2007). Possible future alternative strategies to enable a truly precautionary approach are discussed.
